Biotech firm achieves 500-batch AFEX production milestone
Lansing, Mich. — Sept. 14, 2015: MBI today announced its innovative biomass pretreatment patent (patent no. 9,102,964) has been issued by the USPTO. The granting of this patent represents a major milestone in the development and commercialization of its AFEX technology.
For every ton of corn, wheat, and rice harvested today, an equal amount of biomass is left behind on the fields. Within this biomass — of which nearly 2 billion tons are produced each year around the world — nature locks away huge stores of inaccessible sugars. AFEX technology partners with nature, unlocking these sugars and upgrading the biomass into a sustainable source of both cattle feed or a feedstock for cellulosic biofuels and chemicals.
The AFEX technology is a game-changing agricultural innovation, sustainably expanding our capacity to supply both cattle feed and transportation fuels, while reducing our environmental footprint.
Conceived at MBI in 2010, this latest innovation represents a major breakthrough in the cost, scalability, and commercial viability of the technology.
“What is exciting about this patented breakthrough is that it enables a low-cost production of AFEX pretreated biomass, while cost-effectively recycling and reusing the catalyst used during the process,” said Tim Campbell, MBI’s Project Manager and AFEX Process Engineer — also the lead inventor on the patent. “This innovation makes the AFEX process highly robust as well as simple to reproduce and operate. If not for the design breakthrough covered by this patent, the enormous potential global impact of AFEX technology could not be economically realized.”
The newly issued patent expands the AFEX technology intellectual property portfolio, which Michigan State University (MSU) — and later MBI — have been developing since MSU Distinguished Professor Bruce Dale invented the technology. This patented technology has been successfully scaled 100-fold, leading to the current one-ton-per-day AFEX pilot plant, at MBI’s Lansing, Michigan facility.
In addition to celebrating the issuance of its key patent, MBI recently achieved another milestone: the production of over 500 batches (15 tons) of AFEX pretreated biomass. Taken together, the patent and production milestones demonstrate the technology’s innovativeness, as well as its robust, consistent performance.
“Currently, we are focused on advancing AFEX technology from pilot to demonstration scale in order to showcase its viability and efficacy for both cattle feed and fuels applications,” said Bobby Bringi, MBI’s CEO. “MBI is commercializing this technology on behalf of MSU. Ultimately, our vision is to broadly share this technology to maximize its global societal benefits.”
Allen Julian | 517.336.4613
Aaryn Richard | 517.336.4638
MBI (Michigan Biotechnology Institute) is both a premier multi-disciplinary center sought out by industry partners for unique derisking capabilities — and a mission-inspired 501(c)(3) not-for-profit that collaboratively accelerates the commercialization of biobased, sustainability-minded technologies. MBI is known for pioneering derisking, a process that quickly and cost-effectively weeds out flawed technologies while accelerating viable ones through a stage-gated innovation process. Lansing, Michigan-based MBI engages with universities, research institutions, and corporations to develop sustainable fuels, chemicals, food, and feed. Collaborators have included Bolt Threads, DuPont, Genomatica, and Novozymes. MBI has also worked with Michigan State University and Cargill to develop PLA, the first biodegradable polymer in global use. Technologies developed at MBI are recognized and trusted worldwide. Learn more at www.mbi.org. A video about AFEX technology and its potential impact can be found here.
(Photo of the Chandra Nielson and Josh Videto taken by Trumpie Photography. Illustration by Jennifer Weaver of Weaver Design.)